Notice of AGM & Annual Report & Accounts
ImmuPharma PLC has announced the posting of its Notice of Annual General Meeting and the Annual Report and Accounts for the year ended 31 December 2025 to shareholders. These documents will be available on the company's website, www.immupharma.co.uk. The AGM is scheduled to take place on Thursday, 25th June 2026, at 11:00 am BST.
Select text to share a quote on X · sign in to keep highlights & notes in your IMM notes
ImmuPharma PLC (LSE AIM: IMM), the specialist drug discovery and development company, confirms that the Notice of Annual General Meeting ("AGM") has today been posted to shareholders. The Annual Report and Accounts for the year ended 31 December 2025 has also been posted to shareholders today.
These documents will be available shortly, in electronic form, for download on the Company's website www.immupharma.co.uk.
ImmuPharma's AGM will be held on Thursday 25th June 2026 @ 11:00am (BST) at the offices of Broadfield Law UK LLP, One Bartholomew Close, London EC1A 7BL.
ImmuPharma PLC ( www.immupharma.co.uk )
Tim McCarthy, Chief Executive Officer and Chairman
| Lisa Baderoon, Head of Investor Relations | + 44 (0) 7721 413496 |
| SPARK Advisory Partners Limited (NOMAD) Neil Baldwin Stanford Capital Partners (Joint Broker) Patrick Claridge, Bob Pountney SI Capital (Joint Broker) Nick Emerson | +44 (0) 203 36 8 8974 +44 (0) 203 650 3650 +44 (0) 1483 413500 |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.